Josee S. Hebert

90 South Street
Murdoch, WA 6150, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

Journal: Science advances
Published: May 15, 2026

A national strategy for a canadian limb loss and limb difference registry.

A national strategy for a canadian limb loss and limb difference registry.

Journal: Canadian prosthetics & orthotics journal
Published: April 01, 2026

High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.

High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.

Journal: Biomarker research
Published: May 15, 2025

Unveiling the Complexity of KMT2A Rearrangements in Acute Myeloid Leukemias with Optical Genome Mapping.

Unveiling the Complexity of KMT2A Rearrangements in Acute Myeloid Leukemias with Optical Genome Mapping.

Journal: Cancers
Published: November 14, 2024

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

Journal: Biomarker research
Published: November 06, 2024

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Journal: Leukemia
Published: October 15, 2024

DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.

DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.

Journal: EMBO reports
Published: October 09, 2024

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls.

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls.

Journal: Blood neoplasia
Published: September 30, 2024

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.

Journal: Cytometry. Part B, Clinical cytometry
Published: June 15, 2024

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Journal: Bone marrow transplantation
Published: April 11, 2024

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

Journal: Science advances
Published: March 22, 2024

Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.

Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.

Journal: NPJ precision oncology
Published: January 05, 2024
Showing 1-12 of 87

Last Updated: 09/26/2026